Legionella Risk Assessment & Testing

What is Legionella?

Legionella is a collective term for diseases caused by legionella bacteria, the most serious being Legionnaires' disease. Legionella bacteria are widespread in natural water systems. However, outbreaks of the illness occur most often from exposure to legionella growing in man made systems where water is maintained at a high temperature, encouraging bacteria growth. This can include, cooling towers, evaporating condensers, hot and cold water systems, pools and all sorts of building both domestic and commercial.

Legionnaires’ disease is a real risk and companies need to take health and safety duties to their employees and others seriously. Failing to reduce the risk of Legionnaires' disease from water systems can lead to large fines.

By law, an organisation is responsible for the water systems and they should determine the level of associated risk posed. This is particularly important where more vulnerable persons may be present, e.g. in social housing.

How can IOM help?

We can provide appropriate legionella assessments that include identifying and assessing sources of risk; preparing a scheme to prevent or control risk; a review of the water systems, and implementing, awareness training for workers and finally managing and monitoring the precautionary measures.

  • L8 compliant Legionella risk assessments
  • Legionella surveys
  • Legionella management policy
  • Water testing
  • Awareness and management training

For more advice, or to speak to an Occupational Hygienist to arrange legionella testing complete the quick quote form below. 

EVENTS
20 October
2021
In partnership with the ICBA

Particles and Health 2021

  • 20 October 2021
  • Running from the 20.10.21 to 21.10.21

IOM is proud to be sponsoring the Particles and Health conference, a two day event designed for regulators and researchers to:

  • Address scientific studies regarding human health effects of PSLTs. The value of human studies over animal studies-when human-exposed populations can be studied adequately- will be emphasized.
  • Review and discuss definition of PSLT’s proposed at Edinburgh workshop and published in 2020 in the Journal Inhalation Toxicology with attention to both similarities and differences among these substances.
  • Address translational toxicology challenges, including the appropriateness of rats as models for human lung pathogenesis (particularly lung cancer) in light of lung overload phenomena and species differences.
  • Serve as a platform to present current scientific information about PSLTs important for regulatory action.
  • Publication of pertinent conference presentations in the peer reviewed scientific literature will allow the presentations to live beyond the conference and subsequently be reviewed part of regulatory deliberations.
  • Establish an interdisciplinary setting for industry, academia and regulatory professionals to interact on an important topic. Such interaction can facilitate enhanced understanding of the science and appropriate classification, labelling and setting exposure limits, among others.
  • Recommend areas for further research regarding the significance of the rat as a model for translation toxicology. 
  • Review the biokinetics of inhaled nanoparticles and the potential for non-pulmonary effects.

For more information and tickets please visit the Particles and Health website here.

Event info
We're here to provide you with more information and answer any questions you may have. Contact us